Abstract:Introduction: The clinical use of the antitumoral drug doxorubicin (Dox) is reduced by its dose-limiting toxicity, related to cardiotoxic side effects and myelosuppression. In order to overcome these drawbacks, here we describe the synthesis, the structural characterization and the in vitro cytotoxicity assays of hydrogels (HGs) and nanogels (NGs) based on short peptide sequences loaded with Dox or with its liposomal formulation, Doxil. Methods: Fmoc-FF alone or in combination with (FY)3 or PEG8-(FY)3 peptides, at two different ratios (1/1 and 2/1 v/v), were used for HGs and NGs formulations. HGs were prepared according to the "solvent-switch" method, whereas NGs were obtained through HG submicronition by the top-down methodology in presence of TWEEN®60 and SPAN®60 as stabilizing agents. HGs gelation kinetics were assessed by Circular Dichroism (CD). Stability and size of NGs were studied using Dynamic Light Scattering (DLS) measurements. Cell viability of empty and filled Dox HGs and NGs was evaluated on MDA-MB-231 breast cancer cells. Moreover, cell internalization of the drug was evaluated using immunofluorescence assays. Results: Dox filled hydrogels exhibit a high drug loading content (DLC=0.440), without syneresis after 10 days. Gelation kinetics (20-40 min) and the drug release (16-28%) over time of HGs were found dependent on relative peptide composition. Dox filled NGs exhibit a DLC of 0.137 and a low drug release (20-40%) after 72 h. Empty HGs and NGs show a high cell viability (>95%), whereas Dox loaded ones significantly reduce cell viability after 24 h (49-57%) and 72 h (7-25%) of incubation, respectively. Immunofluorescence assays evidenced a different cell localization for Dox delivered through HGs and NGs with respect to the free drug. Discussion: A modulation of the Dox release can be obtained by changing the ratios of the peptide components. The different cellular localization of the drug loaded into HGs and NGs suggests an alternative internalization mechanism. The high DLC, the low drug release and preliminary in vitro results suggest a potential employment of peptide-based HGs and NGs as drug delivery tools.

Fabrication of Single-Hole Glutathione-Responsive Degradable Hollow Silica Nanoparticles for Drug Delivery.

Peptide-Based Hydrogels and Nanogels for Delivery of Doxorubicin

GSH-responsive polymeric micelles based on the thio–ene reaction for controlled drug release

GSH/pH Dual-Responsive and HA-targeting Nano-Carriers for Effective Drug Delivery and Controlled Release

Mesoporous Silica Nanoparticles Combining Au Particles As Glutathione and Ph Dual-Sensitive Nanocarriers for Doxorubicin.

One-pot Synthesis of Glutathione-Responsive Amphiphilic Drug Self-Delivery Micelles of Doxorubicin-Disulfide-methoxy Polyethylene Glycol for Tumor Therapy.

Γ‐pga‐coated Mesoporous Silica Nanoparticles with Covalently Attached Prodrugs for Enhanced Cellular Uptake and Intracellular GSH‐Responsive Release

Simple Fabrication of Glutathione-Responsive Pegylated Micellar Nanocarriers for Dual Drugs Delivery

Hollow Silica–polyelectrolyte Composite Nanoparticles for Controlled Drug Delivery

A Ph/glutathione Double Responsive Drug Delivery System Using Molecular Imprint Technique for Drug Loading

Ultrasensitive GSH-Responsive Ditelluride-Containing Poly(ether-urethane) Nanoparticles for Controlled Drug Release.

Glutathione- and Ph-Responsive Nonporous Silica Prodrug Nanoparticles for Controlled Release and Cancer Therapy

Synthesis and characterization of a glutathione‐responsive drug delivery system based on aptamer‐coated mesoporous silica

Redox-responsive nanomedicine of doxorubicin-conjugated poly-L-glutathione oxidized for cancer therapy

Glutathione functionalized mesoporous organosilica conjugate for drug delivery

One-pot Fabrication of Ph/reduction Dual-Stimuli Responsive Chitosan-Based Supramolecular Nanogels for Leakage-Free Tumor-Specific DOX Delivery with Enhanced Anti-Cancer Efficacy.

Synthesis and characterization of amphiphilic glycidol-chitosan-deoxycholic acid nanoparticles as a drug carrier for doxorubicin.

Glutathione-mediated mesoporous carbon as a drug delivery nanocarrier with carbon dots as a cap and fluorescent tracer.

Glutathione Responsive Cubic Gel Particles Cyclodextrin Metal-Organic Frameworks for Intracellular Drug Delivery.

Construction and Biological Evaluation of Multiple Modification Hollow Mesoporous Silicone Doxorubicin Nanodrug Delivery System

Glutathione-Responsive Multifunctional “Trojan Horse” Nanogel as a Nanotheranostic for Combined Chemotherapy and Photodynamic Anticancer Therapy